Identification of molecular factors mediating therapeutic resistance in diffuse large B-cell lymphoma (DLBCL)
The prognosis for relapsed and refractory diffuse large B-cell lymphoma (DLBCL) is very poor, emphasizing the critical need to identify the underlying molecular mechanisms and targeted treatments. In this study, we delved into the molecular factors driving therapeutic resistance in DLBCL by conducti...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis-Doctor of Philosophy |
| Language: | English |
| Published: |
Nanyang Technological University
2024
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/174839 |